The identification of FUS mutations in familial and sporadic forms of amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration (FTLD) patients suggests that modifications in RNA metabolism might be an essential event in the disease pathogenesis [4,5]. The gene discussed is FUS; the disease is amyotrophic lateral sclerosis.